BIOMAT Database Logo BIOMAT Database Logo

Slow increase of homovanillic acid in cerebrospinal fluid after levodopa administration. 1996

C Raftopoulos, and S Dethy, and M A Laute, and S Goldman, and A B Naini, and S Przedborski, and J Hildebrand
Service de Neurochirurgie, Hôpital Erasme, Université Libre de Bruxelles, Belgium.

Concentrations of major catabolites of dopamine were followed in the ventricular cerebrospinal fluid (CSF) in five patients undergoing intracranial pressure monitoring for chronic hydrocephalus. Determinations were made every 2 h following the administration of carbidopa/levodopa 25/250 mg (one Sinemet capsule) given 8 h apart. The rise of homovanillic acid (HVA) concentrations was slow and progressive, reaching the level of statistical significance (p < or = 0.01) only 8 h after the second administration of Sinemet. The rise in 3,4-dihydroxyphenylacetic acid (DOPAC) was faster than the rise in HVA, with the peak value detected 4 h after the first administration of Sinemet. These data are interpreted as a confirmation, in humans, of a slow pool of exogenous levodopa, previously demonstrated in animal studies.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002230 Carbidopa An inhibitor of DOPA DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself. Methyldopahydrazine,Carbidopa, (R)-Isomer,Carbidopa, (S)-Isomer,Lodosin,Lodosyn,MK-485,MK-486,MK 485,MK 486,MK485,MK486
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006849 Hydrocephalus Excessive accumulation of cerebrospinal fluid within the cranium which may be associated with dilation of cerebral ventricles, INTRACRANIAL HYPERTENSION; HEADACHE; lethargy; URINARY INCONTINENCE; and ATAXIA. Communicating Hydrocephalus,Congenital Hydrocephalus,Obstructive Hydrocephalus,Post-Traumatic Hydrocephalus,Aqueductal Stenosis,Cerebral Ventriculomegaly,Fetal Cerebral Ventriculomegaly,Hydrocephalus Ex-Vacuo,Hydrocephaly,Aqueductal Stenoses,Cerebral Ventriculomegalies,Cerebral Ventriculomegalies, Fetal,Cerebral Ventriculomegaly, Fetal,Fetal Cerebral Ventriculomegalies,Hydrocephalus Ex Vacuo,Hydrocephalus Ex-Vacuos,Hydrocephalus, Communicating,Hydrocephalus, Congenital,Hydrocephalus, Obstructive,Hydrocephalus, Post-Traumatic,Post Traumatic Hydrocephalus,Stenoses, Aqueductal,Stenosis, Aqueductal,Ventriculomegalies, Cerebral,Ventriculomegalies, Fetal Cerebral,Ventriculomegaly, Cerebral,Ventriculomegaly, Fetal Cerebral

Related Publications

C Raftopoulos, and S Dethy, and M A Laute, and S Goldman, and A B Naini, and S Przedborski, and J Hildebrand
Failure of cerebrospinal fluid homovanillic acid to predict levodopa response in Parkinson's disease.
October 1973, Journal of neurology, neurosurgery, and psychiatry,
C Raftopoulos, and S Dethy, and M A Laute, and S Goldman, and A B Naini, and S Przedborski, and J Hildebrand
Homovanillic acid in cerebrospinal fluid of alcoholics.
June 1973, The New England journal of medicine,
C Raftopoulos, and S Dethy, and M A Laute, and S Goldman, and A B Naini, and S Przedborski, and J Hildebrand
Cerebrospinal fluid homovanillic acid in cerebral infarction.
January 1978, Journal of neural transmission. Supplementum,
C Raftopoulos, and S Dethy, and M A Laute, and S Goldman, and A B Naini, and S Przedborski, and J Hildebrand
Cerebrospinal fluid homovanillic acid in Huntington's chorea.
July 1971, Journal of the neurological sciences,
C Raftopoulos, and S Dethy, and M A Laute, and S Goldman, and A B Naini, and S Przedborski, and J Hildebrand
Lack of changes in ventricular cerebrospinal fluid concentrations of homovanillic acid following acute challenge with levodopa.
January 1992, Annals of neurology,
C Raftopoulos, and S Dethy, and M A Laute, and S Goldman, and A B Naini, and S Przedborski, and J Hildebrand
Cerebrospinal fluid homovanillic acid and iso-homovanillic acid: a gas-liquid chromatographic method.
March 1974, Journal of neurochemistry,
C Raftopoulos, and S Dethy, and M A Laute, and S Goldman, and A B Naini, and S Przedborski, and J Hildebrand
Variations of homovanillic acid levels in ventricular cerebrospinal fluid.
May 1992, Acta neurologica Scandinavica,
C Raftopoulos, and S Dethy, and M A Laute, and S Goldman, and A B Naini, and S Przedborski, and J Hildebrand
Homovanillic acid in the cerebrospinal fluid of Parkinsonian patients.
February 1983, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
C Raftopoulos, and S Dethy, and M A Laute, and S Goldman, and A B Naini, and S Przedborski, and J Hildebrand
[Homovanillic acid concentration of the cerebrospinal fluid in epilepsy].
April 1976, No to shinkei = Brain and nerve,
C Raftopoulos, and S Dethy, and M A Laute, and S Goldman, and A B Naini, and S Przedborski, and J Hildebrand
Physiological doses of estradiol can increase lingual dyskinesia and cerebrospinal fluid homovanillic acid in monkeys.
August 1985, Neuroscience letters,
Copied contents to your clipboard!